SE7807753L - Organiska foreningar, deras framstellning och anvendning - Google Patents

Organiska foreningar, deras framstellning och anvendning

Info

Publication number
SE7807753L
SE7807753L SE787807753A SE7807753A SE7807753L SE 7807753 L SE7807753 L SE 7807753L SE 787807753 A SE787807753 A SE 787807753A SE 7807753 A SE7807753 A SE 7807753A SE 7807753 L SE7807753 L SE 7807753L
Authority
SE
Sweden
Prior art keywords
preparation
associations
organic
organic associations
Prior art date
Application number
SE787807753A
Other languages
English (en)
Other versions
SE435374B (sv
Inventor
R Berethold
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH907777A external-priority patent/CH632246A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7807753L publication Critical patent/SE7807753L/sv
Publication of SE435374B publication Critical patent/SE435374B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
SE7807753A 1977-07-21 1978-07-12 Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning. SE435374B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH907377 1977-07-21
CH907777A CH632246A5 (en) 1977-07-21 1977-07-21 Process for preparing novel 3-aminopropoxyindoles
CH907077 1977-07-21
CH906577 1977-07-21

Publications (2)

Publication Number Publication Date
SE7807753L true SE7807753L (sv) 1979-01-22
SE435374B SE435374B (sv) 1984-09-24

Family

ID=27429188

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7807753A SE435374B (sv) 1977-07-21 1978-07-12 Terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)-indol, deras framstellning och anvendning.

Country Status (18)

Country Link
JP (1) JPS5422364A (sv)
AU (1) AU523105B2 (sv)
BE (1) BE869133A (sv)
CA (1) CA1098909A (sv)
DE (1) DE2830211A1 (sv)
DK (1) DK312878A (sv)
ES (1) ES471863A1 (sv)
FI (1) FI782229A (sv)
FR (1) FR2398058A1 (sv)
GB (1) GB2001971B (sv)
IE (1) IE47131B1 (sv)
IL (1) IL55170A (sv)
IT (1) IT1105092B (sv)
NL (1) NL7807626A (sv)
NZ (1) NZ187909A (sv)
PT (1) PT68317A (sv)
SE (1) SE435374B (sv)
SU (1) SU843740A3 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3068678D1 (en) * 1979-08-10 1984-08-30 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
DE3030047A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
EA002984B1 (ru) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений
ATE215369T1 (de) * 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
AU1580001A (en) * 1999-11-15 2001-05-30 Eli Lilly And Company Process for the preparation of aryloxy propanolamines
KR20190017795A (ko) * 2016-05-13 2019-02-20 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 아드레날린 수용체 조절 화합물 및 이의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547056A (fr) * 1966-12-13 1968-11-22 Sandoz Sa Dérivés de l'indole et leur préparation
FR2019185A1 (en) * 1968-09-30 1970-06-26 Sandoz Sa 4-(2-hydroxy-3-amino-propoxy)-indole-2-carboxy- - lic acids and esters and 2-hydroxymethylindoles as beta
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
US4076829A (en) * 1974-11-16 1978-02-28 Boehringer Mannheim Gmbh Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases
DE2508251C2 (de) * 1975-02-26 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2633839A1 (de) * 1975-08-07 1977-02-24 Sandoz Ag Neue 4-aminopropoxyindolderivate, ihre herstellung und verwendung
DE2635209C2 (de) * 1975-08-15 1983-01-27 Sandoz-Patent-GmbH, 7850 Lörrach 4-(2-Benzoyloxy-3-tert.butylamino-propoxy)-2-methylindol, dessen (S)-Enantiomeres, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Heilmittel

Also Published As

Publication number Publication date
FR2398058A1 (fr) 1979-02-16
BE869133A (fr) 1979-01-19
IE47131B1 (en) 1983-12-28
SE435374B (sv) 1984-09-24
IL55170A0 (en) 1978-09-29
IT1105092B (it) 1985-10-28
DK312878A (da) 1979-01-22
FI782229A (fi) 1979-01-22
PT68317A (fr) 1978-08-01
NZ187909A (en) 1981-04-24
GB2001971B (en) 1982-02-10
SU843740A3 (ru) 1981-06-30
GB2001971A (en) 1979-02-14
IE781448L (en) 1979-01-21
JPS5422364A (en) 1979-02-20
IL55170A (en) 1982-07-30
DE2830211A1 (de) 1979-02-01
IT7850299A0 (it) 1978-07-14
CA1098909A (en) 1981-04-07
AU3818278A (en) 1980-01-24
ES471863A1 (es) 1979-10-01
NL7807626A (nl) 1979-01-23
FR2398058B1 (sv) 1982-08-06
AU523105B2 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
SE7805055L (sv) Organiska foreningar, deras anvendning och framstellning
SE7802022L (sv) Kinazolinforeningar
SE7805136L (sv) Polyenforeningar
SE7805217L (sv) Tiaazaforeningar
SE7803848L (sv) Cykloalkan-substituerade fenylettiksyraderivat, deras anvendning och framstellning
SE7810893L (sv) Alkanoylprolin-derivat och homologer derav, deras framstellning och anvendning
SE7614085L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7807753L (sv) Organiska foreningar, deras framstellning och anvendning
SE7801697L (sv) 1-oxadetiacefamforeningar
SE7701155L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7701352L (sv) Organiska foreningar, deras framstellning och anvendning
SE7807554L (sv) Organiska foreningar
SE7800633L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7801074L (sv) Organiska foreningar, deras framstellning och anvendning
SE7800452L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7606877L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7613182L (sv) Organiska foreningar, deras framstellning och anvendning
SE7805578L (sv) 6-amino-penamforeningar
SE7803040L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7603371L (sv) Organiska foreningar, deras anvendning och framstellning
SE7606405L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7609505L (sv) Organiska foreningar, anvendning och framstellning derav
SE7806852L (sv) Organiska foreningar
SE7710238L (sv) Organiska foreningar, deras anvendning och framstellning
SE7701916L (sv) Organiska foreningar, deras framstellning och anvendning